The Latest Breaking News from Ije Nwokorie

Dr. Martens H2 Earnings Call Highlights

Dr. Martens (LON:DOCS) reported higher full-year profit despite slightly lower revenue, as management said the footwear brand prioritized full-price sales, reduced markdown activity and continued to reshape the business around a consumer-led strategy. Speaking at the company’s FY 2026 results prese

MarketBeat · May 19

Dr Martens to raise prices in the US because of tariff hit

Dr Martens said it remained on track with full-year forecasts.

Evening Standard · Nov 20, 2025

Dr Martens promises not to raise prices this year despite US tariffs

UK footwear brand says it will continue to source bulk of its shoes from Laos and Vietnam ‘through tough times’

The Guardian - UK · Jun 5, 2025

Dr Martens swings to loss and braces for currency hit

The bootmaker reported pre-tax losses of £28.7 million for the six months to September 29 against profits of £25.8 million the previous year.

The Independent UK · Nov 28, 2024

Dr Martens CEO to go after latest profit warning

Its struggles in the US have continued, with the Autumn/Winter order book “significantly down year-on-year”, which could cost £20 million in profits

Evening Standard · Apr 16, 2024